A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis

PHASE3CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

December 21, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Keratosis, Actinic
Interventions
DRUG

Tirbanibulin

Participants will apply tirbanibulin ointment topically on the face or balding scalp with AK.

OTHER

Vehicle ointment

Participants will apply vehicle ointment topically on the face or balding scalp with AK.

Trial Locations (35)

Unknown

Site 17, Augsburg

Site 1, Bad Bentheim

Site 3, Bochum

Site 18, Dresden

Site 2, Hamburg

Site 5, Hamburg

Site 4, Mahlow

Site 6, Wuppertal

Site 24, Bari

Site 25, Bologna

Site 19, Brescia

Site 26, Cagliari

Site 23, Florence

Site 22, Pisa

Site 27, Reggio Emilia

Site 20, Roma

Site 21, Roma

Site 7, Roma

Site 29, Heemstede

Site 28, Maastricht

Site 31, Krakow

Site 30, Ossy

Site 10, Warsaw

Site 11, Warsaw

Site 9, Warsaw

Site 8, Wroclaw

Site 12, Barcelona

Site 14, Barcelona

Site 34, Barcelona

Site 33, Granada

Site 13, Madrid

Site 32, Salamanca

Site 15, Valencia

Site 35, Valencia

Site 16, Zaragoza

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Almirall, S.A.

INDUSTRY